article · Supportive Care in Cancer
PURPOSE: This study aimed to investigate the impacts of breast cancer-related lymphedema (BCRL) severity on shoulder function including range of motion, strength, muscle activation patterns, and patient-reported disability. METHODS: A cross-sectional, observational study design was utilized. Seventy-five women with unilateral BCRL were recruited and categorized into mild, moderate, and severe groups based on limb swelling severity. Outcomes included shoulder range of motion, isometric strength, Disabilities of Arm Shoulder and Hand (DASH) scores for disability, and surface electromyography (EMG) of shoulder muscles. Data were analyzed using parametric and nonparametric tests. RESULTS: Increasing lymphedema severity was associated with progressive declines in shoulder mobility, strength, and function. Severe cases showed markedly reduced shoulder flexion, abduction, rotation, and extension range of motion along with decreased isometric flexor and abductor strength versus mild cases (p < 0.001). Higher pain levels (p < 0.001) and DASH disability scores (p < 0.001) were noted in severe BCRL. Surface EMG revealed impaired activation patterns including reduced amplitudes (p < 0.001) and delayed onsets (p < 0.001) in the deltoids, rotator cuff, and scapular muscles with greater impairment. CONCLUSIONS: Advancing BCRL severity was associated with substantial declines in shoulder mobility, strength, neuromuscular activation, pain threshold, and upper limb functionality. These quantitative results demonstrate impaired shoulder joint control underlying disability in arm elevation and daily tasks. The progressive nature of these deficits highlights the relationship between lymphedema severity and shoulder dysfunction in breast cancer survivors.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s00520-024-09044-7
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.